170664 ⎘
Assays involving biological materials from specific organisms or of a specific nature; Enzymes; Proenzymes; Hydrolases (3) acting on peptide bonds (3.4) Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
Sub-classes:METHODS AND APPARATUSES FOR DETECTING BIOMOLECULE AND ANALYTE INTERACTIONS
#2POLYPEPTIDE CAPTURE, IN SITU FRAGMENTATION AND IDENTIFICATION
#3Apparatus and Processes for Magnetic Detection of an Analyte
#4POLYPEPTIDE SEQUENCING REAGENTS AND METHODS OF USE
#5COMPOUND-DIAGNOSTIC MARKER FOR UTERINE BODY CANCER, METHOD FOR DETECTING ENZYMATIC ACTIVITY, METHOD FOR DIAGNOSIS OF UTERINE BODY CANCER, KIT COMPRISING THE COMPOUND, USES OF THE COMPOUND AND METHOD FOR THE TREATMENT OF UTERINE BODY CANCER
#6METHODS FOR DETERMINING ONE OR MORE CRITICAL QUALITY ATTRIBUTES OF CO-FORMULATED ANTIBODIES
#7SIGNAL AMPLIFICATION AND MULTIPLEXING USING MASS TAGS FOR IA-LC-MS/ MS BASED ASSAYS
#8DETECTION AND QUANTIFICATION OF ANTI-DRUG ANTIBODIES AND ANTI-SELF ANTIBODIES
#9STRUCTURE AND FUNCTION CHARACTERIZATION OF ADENO-ASSOCIATED VIRUS (AAV) BY HDX-MS
#10METHODS OF PROTEIN ANALYSIS
#11COMPOSITION FOR DIAGNOSING CANCER
#12CYANINE DYES AND THEIR BIOLOGICAL CONJUGATES
#13METHOD FOR OPTIMIZING MRNA SEQUENCE USING PEPTIDE BARCODE
#14MARKER, KIT AND METHOD FOR ANALYSING A BIOLOGICAL SAMPLE
#15PEPTIDASE CLEAVABLE SUBSTRATES AND METHODS OF IDENTIFICATION AND USE THEREOF
#16FRET ENZYMATIC SUBSTRATE AND USES THEREOF IN LUNG CANCER
#17METHOD FOR DETECTING PROTEIN HAVING CHANGES IN ENERGY STATE, OR AFFINITY OF LIGAND TO PROTEIN
#18COMPOSITIONS AND METHODS FOR DETECTING PROTEASE ACTIVITY IN BIOLOGICAL SYSTEMS
#19METHOD OF AND AN APPARATUS FOR DETERMINING DIETARY FIBER AND A SAMPLE CONTAINER SYSTEM FOR USE THEREIN
#20TRICYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF CANCER, AUTOIMMUNE AND INFLAMMATORY DISORDERS
#21METHODS OF QUANTIFYING ANTI-CD40 ANTIBODIES
#22POLYPEPTIDE CAPTURE, IN SITU FRAGMENTATION AND IDENTIFICATION
#23Detecting microbial infection in wounds
#24BARCODED XTEN POLYPEPTIDES AND COMPOSITIONS THEREOF, AND METHODS FOR MAKING AND USING THE SAME
#25Methods, Systems & Kits for Prediction, Detection, Monitoring & Treatment of Alzheimer's Disease
#26Ex vivo protease activity detection for disease detection/diagnostic, staging, monitoring and treatment
#27TARGETED CATALYTIC COMPLEMENT-ACTIVATING MOLECULES AND METHODS OF USE THEREOF
#28Ex vivo protease activity detection for disease detection/diagnostic, staging, monitoring and treatment
#29BIOMARKERS FOR DIAGNOSIS OF OCULAR DISEASES AND THE METHOD THEREOF
#30EX VIVO PROTEASE ACTIVITY DETECTION FOR DISEASE DETECTION/DIAGNOSTIC, STAGING, MONITORING AND TREATMENT
#31Ex vivo protease activity detection for disease detection/diagnostic, staging, monitoring and treatment
#32RAPID MEASUREMENT OF TOTAL VITAMIN D IN BLOOD
#33Methods Employing Mucin-Specific Proteases
#34Compositions and methods for detecting protease activity in biological systems
#35CANCER-RELATED ACTIVITY SENSORS
#36Hybridoma cell strain and monoclonal antibody produced therefrom against serine protease of in intestinal stage and application thereof
#37Construct including an anchor, an enzyme recognition site and an indicator region for detecting microbial infection in wounds
#38Antibodies for prevention, treatment and diagnosis of infection
#3918F labeling of proteins using sortases
#40High-throughput single molecule protein identification
#41Blood profiling with protease inhibitors
#42Detection, identification, and purification of degradative and non-degradative enzymes in biological samples
#43Biomarker Panel For Diagnosing Cancer
#44Compositions and methods for detecting protease activity in biological systems
#45METHOD TO DETERMINE BRAF MUTATIONS AND WILD TYPE BRAF PROTEIN BY MASS SPECTROMETRY
#46GENERATION OF PEPTIDES
#47Methods of preparing antibodies
#48PROGNOSIS OF SEROUS OVARIAN CANCER USING BIOMARKERS
#49METHODS AND COMPOSITIONS FOR ASSAYING BLOOD LEVELS OF LEGUMAIN
#50Skin treatment devices and methods with pre-stressed configurations
#51ASSAYS FOR EVALUATING CELL CULTURE REAGENTS
#52Biomarker panel for diagnosing cancer
#53Nanopatterned extracellular matrices enable cell-based assays with a mass spectrometric readout
#54Therapeutic use for αproteinase inhibitor in hematopoiesis
#55BIOMASS CONTAINMENT DEVICE
#56Biomarkers and assay to detect chronic graft versus host disease
#57Methodologies for measuring isopeptidase activity in biological samples in a high throughput manner
#58Optical biosensor
#59Protein retention expansion microscopy
#60MULTIPLEX ENZYME ASSAY USING MASS SPECTROMETER-BASED FLOW CYTOMETER
#61Methods and kits for measuring protease activity in feed
#62F labeling of proteins using sortases
#63Method of generating linkage-specific di-and polyprotein probes
#64Skin treatment devices and methods with pre-stressed configurations
#65PCSK9 Function Assay
#66Method for detecting a target analyte that exhibits protease enzyme activity
#67METHOD FOR QUANTIFYING GLYCATED HEMOGLOBIN
#68Methods and compositions for identifying a peptide having an intermolecular interaction with a target of interest
#69Synzymes
#70PCSK9 Function Assay
#71Enzyme sensors, methods for preparing and using such sensors, and methods of detecting protease activity
#72Compositions and methods for detecting protease activity in biological systems
#73Method for determining the spatiotemporal distribution of activity of a proteolytic enzyme in a heterogeneous system (variations), a device for realizing same and a method for diagnosing the defects in the hemostatic system on the basis of a change in the spatiotemporal distribution of activity of a proteolytic enzyme in a heterogeneous system
#74ERAP1-derived peptide and use thereof
#75Skin treatment devices and methods with pre-stressed configurations
#76METHOD FOR DIAGNOSIS NON-SMALL-CELL-LUNG-CARCINOMA (NSCLC) AND CLASSIFICATION OF ITS SUBTYPES WITH DIFFERENT COMBINATIONS OF 6 PROTEIN BIOMARKERS
#77Screening strategies for the identification of binders
#78Therapeutic use for ALPHA1 proteinase inhibitor in hematopoiesis
#79USP47 inhibitors and methods to induce apoptosis
#80Antibodies and methods of use thereof
#81Cyanine dyes
#82Treatment devices and methods with extending elements
#83Skin treatment devices and methods with pre-stressed configurations
#84Releasable nonvolatile mass-label molecules
#85Method of determining the oligomeric state of a protein complex
#86DIAGNOSTIC METHOD OF SKIN INFLAMMATORY DISEASE
#87Diagnosis of infection based on detection of bacterial secreted biomarkers
#88Homogeneous activity test for determining enzymatic reactions
#89Prevention, treatment and diagnosis of infection
#90Fluorescent cyclic peptides, preparation method thereof and use of these peptides for measuring the enzymatic activity of a protease enzyme
#91AZUROPHILIC GRANULE PROTEASES AS MARKERS IN CARDIOLOGICAL DISEASES
#92METHOD FOR THE ANALYSIS OF O-LINKED OLIOSACHARIDES
#93Methods for Assessing CDK5 Activation and Function
#94Method of pretreating specimen and immunoassay using the same
#95Methods for detecting virulent , for evaluating virulence, and for screening new drugs employing the 3′ UTR of SUB2 and the SUB2 serine protease
#96Fret assays, methods for performing the assays and compounds relevant to the assays
#97USE OF BIOMARKERS FOR THE DIAGNOSIS AND PROGNOSIS OF LUNG CANCER
#98Methods of detecting mastitis by levels of proteasomes
#99TUMOUR-CELL-FIXING CELLS
#100Babesia Subtilisin
#101Methods for screening candidate agents for modulating prorenin and renin, assays for detecting prorenin and antibodies
#102SCREENING METHOD UTILIZING NOVEL SUBSTRATE C-RET FOR GAMMA-SECRETASE
#103Detection Assays and Use Thereof
#104Expression of the cysteine protease legumain in vascular and inflammatory diseases
#105Cyanine dyes
#106Targeted delivery to legumain-expressing cells
#107Enzyme sensors, methods for preparing and using such sensors, and methods of detecting protease activity
#108Alpha1 proteinase inhibitor peptides methods and use
#109Method for screening a protease
#110ANALYTICAL METHOD FOR ANALYZING C-TERMINUS TRUNCATION
#111Methods and Compositions for Identifying a Peptide Having an Intermolecular Interaction With a Target of Interest
#112USP47 inhibtors and methods to induce apoptosis
#113Reagent for digestion of hemoglobin
#114Methods to detect tumors using 20P1F12/TMPRSS2 expression
#115METHOD OF SCREENING USING c-MET, A NOVEL SUBSTRATE FOR GAMMA-SECRETASE
#116Methods for the treatment or prevention of scars and/or keloids
#117Methods for assessing CDK5 activation and function
#119Method of assaying glycated protein
#120Methods and Composition for Diagnosing and Treating Cancer
#121Bead-based radioimmunoassay
#122Hemoglobin A1c determination method, enzyme to be used therefor, and production method thereof
#123THERAPEUTIC USE FOR ALPHA1 PROTEINASE INHIBITOR IN HEMATOPOIESIS
#124Method Of Pretreating Specimen And Immunoassay Using The Same
#125Method of detecting thrombosis by measuring von Willenbrand factor-cleaving protease
#126Expression of the cysteine protease legumain in vascular and inflammatory diseases
#127Metal ion mediated fluorescence superquenching assays, kits and reagents
#128Reagent containing protease reaction promoter and/or colorant stabilizer
#129Use of protein PSA3 as a marker for colorectal cancer
#130Methods for the determination of protein three-dimensional structure employing hydrogen exchange analysis to refine computational structure prediction
#131Ligands for 17i as modulators of orthopox viruses and methods for discovery thereof
#132Methods for detecting virulent , for evaluating virulence, and for screening new drugs employing the 3′UTR of SUB2 and the SUB2 serine protease
#133Methods and composition for derepressions of IAP-inhibited caspase
#134Targeted delivery to legumain-expressing cells
#135Novel tumor antigen useful in diagnosis and therapy of prostate and colon cancer
#136Cyanine dyes
#137Method of analyzing enzyme compositions with lipolytic, proteolytic and amylolytic activity
#138Rapid measurement of total vitamin D in blood
#139Rapid measurement of total vitamin D in blood
#140Compositions and methods for identifying agents for treating apoE-related diseases